Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.
3 registered trials, newest registry update first. Showing only trials linked to Berobenatide.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity NCT07400679 | Berobenatide | Phase 1 | Completed | Pfizer | 48 | Jul 2, 2026 | Aug 17, 2026 |
| A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity NCT07508241 | Berobenatide | Phase 1 | Active not recruiting | Pfizer | 22 | Jan 27, 2027 | Jul 9, 2026 |
| A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function NCT07519135 | Berobenatide | Phase 1 | Recruiting | Pfizer | 26 | Jul 9, 2027 | Apr 23, 2026 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.